Table 3.
Cumulative Detection of Human Papillomavirus Among 218 Concordant Human Immunodeficiency Virus–Negative Couples and 45 Concordant Human Immunodeficiency Virus–Positive Couples With Complete Follow-up From Baseline Through 2 Years
| HPV detected | HIV−/HIV− (n = 218) | HIV+/HIV+ (n = 45) | ||||
|---|---|---|---|---|---|---|
| Baseline | Year 1 | Year 2 | Baseline | Year 1 | Year 2 | |
| No detectable HPV in either partner, no. (%) | 51 (23%) |
29 (13%) | 22 (11%) | 1 (2%) |
0 (0%) |
0 (0%) |
| Any HPV genotype detected in either the male or female partner, no. (%) | 167 (77%) | 189 (86%) | 196 (89%) | 44 (97%) |
45 (100%) | 45 (100%) |
| ≥1 of the same HPV genotype detected in both partners, no. (%) | 70 (32%) | 110 (50%) | 130 (60%) | 34 (76%) |
41 (91%) | 43 (96%) |
| Total number of HPV genotypes detected in the male and female partner, mean (SD) | 2.4 (2.5) | 3.5 (3.3) | 4.5 (3.9) | 6.4 (3.7) | 8.5 (4.1) | 9.6 (4.4) |
| Total number of HPV genotypes detected in both partners, mean (SD) | 0.5 (0.8) | 0.9 (1.3) | 1.2 (1.6) | 2.1 (1.8) | 3.4 (2.4) | 4.1 (2.8) |
Abbreviations: HIV, human immunodeficiency virus; HPV, human papillomavirus; SD, standard deviation.